Related Experiment Video
Updated: Mar 18, 2026
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
995
Does finding early recurrence improve outcomes, and at what cost?
Anh-Thu Le1, Ching-Wei D Tzeng1
1Department of Surgery, University of Kentucky Medical Center, Lexington, Kentucky.
Journal of Surgical Oncology
|July 10, 2016
Summary
Cancer surveillance aims for early recurrence detection when treatment is feasible. Effective surveillance needs personalization based on cancer specifics and patient factors, yet current guidelines lack robust data.
Area of Science:
- Oncology
- Surgical Oncology
- Cancer Care
Background:
- Post-treatment cancer surveillance is crucial for early recurrence detection.
- Current surveillance guidelines lack comprehensive data compared to cancer treatment protocols.
- Effective surveillance ensures timely intervention when cancer and patients remain treatable.
Purpose of the Study:
- To highlight the importance of early cancer recurrence detection through surveillance.
- To emphasize the need for tailored surveillance strategies in cancer survivorship.
- To address the data limitations in current post-cancer treatment surveillance guidelines.
Main Methods:
- Review of current surveillance practices in cancer care.
- Analysis of factors influencing surveillance effectiveness (stage, tumor biology, survival, treatment options).
- Comparison of data supporting surveillance versus treatment protocols.
Main Results:
- Surveillance's primary goal is early detection of treatable cancer recurrence.
- Personalized surveillance approaches are essential for cost-effectiveness and clinical utility.
- A significant gap exists in high-level evidence for surveillance protocols compared to treatment.
Conclusions:
- Optimizing cancer surveillance requires individualized plans based on patient and disease characteristics.
- Enhanced data and evidence are needed to strengthen current surveillance guidelines.
- Improved surveillance strategies are vital for effective long-term cancer patient management.
Related Concept Videos
01:21Cancer Survival Analysis
812
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
812
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
520
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520
01:11Clinical Trials: Overview
5.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K